Scientific advancements are increasingly turning what was once impossible into what is achievable. Griffin Catalyst identifies and invests in early research and timely solutions that have transformational potential to drive progress for current and future generations.
our impact stories
Pioneering a Breakthrough in Treating Parkinson’s Disease
As researchers work toward a cure for Parkinson’s disease, they have discovered a crucial link between a protein called alpha-synuclein and the debilitating neurodegenerative disease.
Partnering with The Michael J. Fox Foundation, Griffin Catalyst funded a competition which challenged researchers to develop a tool to visualize and trace alpha-synuclein in the living human brain for the first time. The competition’s promising results have catapulted the field forward and have put us on a path to revolutionizing care for millions of Parkinson’s patients around the world.
Leveraging Big Data for Scientific Progress
The digital transformation has placed data at the center of just about every industry. Perhaps nowhere is the opportunity more significant, or less realized, than medicine, where big data has the potential to revolutionize our understanding and treatment of disease.
Griffin Catalyst is advancing this effort through the support of Nightingale Open Science and the Open Datasets Initiative, enabling the world’s leading researchers to leverage machine learning and predictive analytics to solve some of medicine’s most important and urgent challenges.
Advancing the Prevention and Treatment of COVID-19
In early 2020, a global pandemic was imminent and the need for action was urgent. Ken Griffin assessed both the scale of the crisis and the scope of the response required to overcome it.
From rapid testing and convalescent plasma therapies to COVID-19 bioresource repositories, funding from Griffin Catalyst delivered critical innovations to help fight the pandemic. Griffin was also instrumental in architecting Operation Warp Speed‘s accelerated vaccine development—delivering safe, effective COVID-19 vaccines in record time and helping to save many millions of lives.
Ever imaging of alpha-synuclein in the living human brain—a critical step toward understanding Parkinson’s
Now-digitized images that can be leveraged with AI to better identify high-risk breast cancer
Countries to be equipped with preparedness models to better manage future pandemics
- Barts Health NHS Trust
- Boston Children's Hospital
- Broad Institute
- Coalition for Epidemic Preparedness Innovations (CEPI)
- Convergent Research
- Imperial College London
- Mount Sinai Health System
- Nightingale Open Science
- Open Datasets Initiative
- The Michael J. Fox Foundation
- The Rockefeller University
- Weill Cornell Medicine